Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer

BACKGROUND: Non-invasive liquid biopsies could complement current pathological nomograms for risk stratification of prostate cancer patients. Development and testing of potential liquid biopsy markers is time, resource, and cost-intensive. For most protein targets, no antibodies or ELISAs for effici...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetze, Sandra, Schüffler, Peter, Athanasiou, Alcibiade, Koetemann, Anika, Poyet, Cedric, Fankhauser, Christian Daniel, Wild, Peter J., Schiess, Ralph, Wollscheid, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044739/
https://www.ncbi.nlm.nih.gov/pubmed/35477343
http://dx.doi.org/10.1186/s12014-022-09349-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044739/
https://www.ncbi.nlm.nih.gov/pubmed/35477343
http://dx.doi.org/10.1186/s12014-022-09349-x

Ejemplares similares